400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
As part of its strategy, the fund employs a passive or indexing approac More
Webiste
Directors
Oct 13, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Price
- $ 38.23 ( +1.41 )
-
Feb 15, 2024Last Close
- Net Assets
-
$7.5B
Mar 27, 2024
- 52-Week High/Low
- $0 - $0
- Expense Ratio
- -
Performance
YTD
0%
3 Year
5.87%
5 Year
35.09%
Best
28.87%
2013
Worst
-68.53%
2015
Company Name |
Holding |
ASML Holding NV | 4.65 % |
Novo Nordisk A/S | 3.6 % |
Shell PLC | 2.85 % |
Nestle SA | 2.75 % |
Roche Holding AG | 2.29 % |
LVMH Moet Hennessy Louis Vuitton SE | 2.2 % |
AstraZeneca PLC | 2.18 % |
Allianz SE | 1.93 % |
Novartis AG | 1.75 % |
BHP Group Ltd | 1.71 % |
More | 1.71 % |
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IQLT | 0% | 1.8% | 16% | -16% | 10.6% | 8% | 25.1% | -10.8% | 24% | -0.1% | |
S&P 500 | -8.8% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 1.8% | 9% | -4.4% | 2.2% | -19.9% | 13% | -1.3% | 7.8% | 0% | ||||
q2 | 0% | 0% | 0.9% | -16.1% | 8.2% | 13.8% | 2.4% | 1.6% | 6.2% | -0.2% | ||||
q3 | 0% | 0% | -5.6% | -10.2% | -1.8% | 4.6% | -2% | 3.5% | 5.2% | 4.8% | ||||
q4 | 0% | 0% | 13.4% | 16.6% | 4% | 13.4% | 8.8% | -12.4% | 3% | -4.5% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | -0.4% | 2.2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |